<DOC>
	<DOCNO>NCT01922115</DOCNO>
	<brief_summary>Anticholinergic medication use treat overactive bladder ( OAB ) . A known side effect medication cognitive dysfunction . OAB prevalent elderly population - group also high baseline risk cognitive dysfunction . Our objective evaluate effect anticholinergic medication cognitive function elderly woman .</brief_summary>
	<brief_title>The Effect Anticholinergics Cognitive Function Elderly</brief_title>
	<detailed_description>Subjects randomize : 1 ) trospium chloride 2 ) placebo . There three aim : 1 . To evaluate change cognitive function elderly woman take trospium versus placebo , use validated cognitive assessment test 2 . To develop useful battery cognitive screening test monitor cognitive safety OAB management 3 . To understand time cognitive change relate time improvement OAB symptom . The investigator recruit 60 woman age â‰¥ 50 diagnosis OAB . Cognitive assessment perform baseline Week 1 4 drug initiation use paper-based validated questionnaire . OAB improvement assess validated questionnaire .</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Trospium chloride</mesh_term>
	<mesh_term>Cholinergic Antagonists</mesh_term>
	<criteria>Female 50 old Diagnosis OAB ( ICS definition ) English literacy Ability swallow oral medication Cognitive ability give consent Dementia/Depression/Delirium Current anticholinergic use ( require 2 week washout period ) Current cholinesterase Urinary gastric retention Severe decrease gastrointestinal motility Uncontrolled narrowangle glaucoma Myasthenia gravis Diagnosis fo renal impairment ( creatinine clearance &lt; 30 mL/min )</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>COGNITIVE FUNCTION</keyword>
	<keyword>OVERACTIVE BLADDER</keyword>
	<keyword>[ C23.888.942.343.780 ]</keyword>
</DOC>